Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases. We are committed to developing novel and transformative medicines to create a better future for people in critical need of new treatment options. Our product portfolio is designed to make a significant impact on neurodegenerative and rare peripheral amyloid diseases, which affect millions of people and their families worldwide. We leverage insights around neurological dysfunction and the biology of misfolded proteins to develop novel therapeutic solutions that directly target pathogenic proteins in order …

95 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Developing mRNA vaccines and therapeutics In September 2021, Sanofi acquired Translate Bio, a clinical-stage mRNA therapeutics company. This acquisition further accelerates Sanofi’s efforts to develop transformative vaccines and therapies using mRNA technology. It adds a critical pillar to the company’s mRNA Center of Excellence, which aims to unlock the potential of next-generation mRNA vaccines and other strategic areas such as immunology, oncology, and rare diseases. Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We …

144 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Orikine Bio is a pioneering biotech company dedicated to advancing the field of engineered cytokines with unparalleled biological features for the treatment of immune-mediated diseases. Our core mission is to unlock the untapped potential of cytokines, enabling us to offer transformative therapies that have the power to reshape the lives of patients around the globe.

59 similar entities Type: Startup Activities: deeptech biotech

Transform how you model human biology. Ricoh Biosciences is a global leader in biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human biology and accelerating …

91 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Care without compromise. We go beyond the conventional role of providing medical devices. At Zebra Medical, we’re dedicated to improving patients’ quality of life by partnering with healthcare professionals across oncology, ultrasound, vascular access, and acute pain management. We deliver specialised, research-backed medical solutions and technology — all with compassion and outstanding service.

146 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

We are shaping the future of insect control. Biocentis is a pioneering life-science company creating a new class of products: genetically engineered insects designed to control harmful species that threaten public health, agriculture, and biodiversity. Spun out of Imperial College London and backed by leading climate and deep-tech investors, we harness cutting-edge genome engineering and a proprietary technology platform to deliver highly effective, sustainable, and environmentally responsible insect control solutions. With teams in the UK and Italy, we bring together a diverse and accomplished group of experts who have built companies worth billions, pioneered CRISPR technologies, and delivered some of …

69 similar entities Type: Startup Activities: deeptech Technologies: Decarbonization

less complexity. more biology. At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis

931 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Innovation, precision, and purpose - redefining infection diagnostics for better outcomes. At Noscendo, we save and improve lives by revolutionising infection diagnostics. Through our metagenomic technology DISQVER®, we empower clinicians to identify pathogens rapidly, precisely, and without assumptions — helping patients receive the right treatment at the right time. We believe in a future where infectious diseases no longer claim lives unnecessarily. Driven by our values, we act with openness and reliability, always put patients first, grow and empower each other, and innovate to elevate modern medicine. We take ownership — and deliver results that matter.

87 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration.

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field. Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field. Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases. We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives.​ Committed to innovation, Da Volterra develops products intended to protect the intestinal …

89 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Pushing the boundaries of neuroscience to transform the treatment of mental illness. Karuna Therapeutics, Inc. is now part of Bristol Myers Squibb. Learn about how we are continuing to transform the lives of patients with neurological and neuropsychiatric diseases @Bristol Myers Squibb or www.bms.com.

60 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Pioneers in nanotechnology-based cancer treatment MagForce is forging new paths to treat cancer successfully and gently. With NanoTherm® Therapy System (NTTS), we have developed an innovative approach based on nanotechnology, which we want to make available to patients worldwide. And we are getting closer and closer to this goal. NTTS is the first and only nanotechnology-based therapy with European approval for treating recurrent Glioblastoma, a deadly brain tumor. To date, many patients diagnosed with Glioblastoma tumors have improved their quality of life after using our technology. Nanomedicine, Oncology, Brain Tumor, Nanotechnology, Glioblastoma, Prostate Cancer, Medical Devices, Medical Technology, and Thermotherapy

73 similar entities Type: SMB Activities: healthtech deeptech nanotech biotech Technologies: Synthetic Biology

Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. 🏔 Explore beyond possible. 🦿 Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. Product design, Medical devices, Innovation design engineering, Innovation, Parkinson's, Diabetes, Gait disorders, Data science, and Remote monitoring

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Peptide Intelligence for Smarter Formulations Nature’s Most Powerful Peptides, Discovered by AI We use artificial intelligence to unlock cell-signaling peptide ingredients for your product formulations. Discovered by AI, validated by human clinical studies, ready for your innovations. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions. Pure peptides, Peptide mixtures, Hydrolysates, Multi targeted peptides, Bioinformatics, Artificial intelligence for drug discovery, Peptide drugs, and …

141 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Propelling breakthroughs in neuroscience from lab to life Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The CNS team combines deep domain expertise with a track-record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity and happiness. brain science, investment, Neuro-Wellness, Innovation, Human-centered design, Human-centered products, Neuroscience, Research, and Venture Building

30 similar entities Type: SMB Activities: healthtech

Treating the individual, not just the disease, through personalized and optimized dosing. We need to shift to a world where we treat the individual, not just the disease. Our inventions work in combination with medicine to deliver personalized, optimized dosing, to provide bespoke universal healthcare access and improve outcomes for patients with chronic diseases. Closed Loop Medicine is a TechBio company developing combination prescription drug + software products, with the aim of bringing forward the promise of precision care. Our proprietary technology platform facilitates personalized drug dose optimization through integration of medicines and software with patient-led digital experiences and closed …

85 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

We are unlocking pathways to be. We are Compass, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. We believe people living with mental health conditions deserve the possibility of a better future. Our initial focus is advancing COMP360, a proprietary, investigational synthetic psilocybin treatment being evaluated for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability, with infrequent dosing. We’re driven by our purpose of unlocking pathways to be—opening futures filled with …

72 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

We invent for life! At MSD - known as Merck & Co., Inc. in the United States and Canada, headquartered in Rahway, New Jersey - we are united by our purpose of harnessing the potential of science to save and improve lives around the world. For more than 130 years, we have provided hope through the development of important medicines and vaccines. We aspire to be the world's leading biopharmaceutical research company and are currently at the forefront of research into innovative health solutions to advance the prevention and treatment of human and animal diseases. We foster a diverse and …

237 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Giving Life to Science PureTech Health is a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value. We do this through a proven, capital-efficient R&D model focused on opportunities with validated pharmacology and untapped potential to address significant patient needs. This strategy has produced dozens of therapeutic candidates, including three that have received U.S. FDA approval. By identifying, shaping, and de-risking these high-conviction assets, and scaling them through dedicated structures backed by external capital, we accelerate their path to patients while creating sustainable value for shareholders. For more information, visit www.puretechhealth.com or connect with us …

182 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Providing new health solutions to improve human life. For over 40 years, Octapharma has become the largest privately owned and independent plasma fractionation company in the world. With more than 11,000 dedicated employees, we provide high-quality, life-saving medicines from human plasma and human cell lines. Every day, we work to improve the lives of patients, creating deep meaning for our donors and employees. We support the treatment of patients in 120 countries. Our efforts focus on three therapeutic areas: immunotherapy, hematology and critical care. Octapharma operates seven R&D sites, five production sites in Austria, France, Germany and Sweden, and more …

147 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products.

60 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

A leading European provider of innovative healthcare and lifestyle solutions based on preventive genetic testing. GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests. With over 18 years of experience in the market, GenePlanet collaborates with over 5000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures. GenePlanet adheres to the highest standards of quality and is constantly …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Customized Bioprinting systems and Bioreactors. Creating Life Changing Futures. REGEMAT3D develops customized Bioprinting Systems and Bioreactors - BMAP. We create Living Tissue Technologies. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve people ́s quality of life. bioprinting, regenerative medicine, biotechnology, and tissue engineering

71 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

Leading human cryopreservation. Tomorrow.bio is advancing biostasis by providing high-quality cryopreservation services in the heart of Europe. As the world’s fastest-growing cryopreservation company with 800+ members, our mission is simple: to enable people to choose how long they want to live. We're optimistic about the future, the power of technology, and—above all—life itself. Our international team of doctors, engineers, and entrepreneurs is young, driven, and committed to making medical time travel a reality. With a pricing model designed for transparency, flexibility, and long-term value, we’re making cryopreservation more accessible than ever. Join us—and get ready for tomorrow 💙 https://member.tomorrow.bio/signup/start

49 similar entities Type: Startup Activities: deeptech biotech

Building Extraordinary Lives® with proven, cutting-edge dietary supplements and skin care products. Cerule® is a biotech company that sells proven, one of a kind dietary supplements, skin care and wellness products. Our products are validated by years of scientific research and development, patents and published scientific papers. We challenge the status quo and are constantly striving to find and develop groundbreaking health solutions that produce positive changes to help you live a longer, healthier and happier life. It is with this mission that Cerule has been positively impacting countless lives worldwide for more than a decade. We believe the extraordinary …

61 similar entities Type: SMB Activities: biotech deeptech healthtech cosmetics Technologies: Synthetic Biology

Doing the extraordinary to restore the ordinary Amber Therapeutics was founded in 2021 with a mission to develop and deliver breakthrough neuromodulation therapies that can fundamentally transform outcomes in areas of unmet clinical need. With the acquisition of Finetech Medical Limited and Bioinduction Ltd in 2023, we are continuing to be the only UK based company in the field of designing and manufacturing long-term implantables. We have since grown into a multidisciplinary team, combining deep medical device experience with a culture and mindset focused on transformational innovation. Amber UI is the company’s first therapy, aiming to restore normal physiological function …

105 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Air Liquide Medical Systems is the subsidiary of Air Liquide Healthcare that is dedicated to Medical Devices. The company develops, manufactures and sells innovative products in three fields: ventilation (ventilators and patient interfaces for intensive care, emergency care, transport, home), equipment for medical gases and aerosol therapy. We engage for people who strive for life, by inventing the easiest to use device and transforming the standards of care. We engage to offer a better quality of life to patients. Our values are: innovation, simplicity, quality, engagement and team spirit. dispositifs médicaux, ventilateurs, and masques

256 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Leading biotech in the development of innovative microbiome-based biotherapies YSOPIA Bioscience is a clinical-stage biotech company developing cutting-edge biotherapies based on the gut microbiome. Our goal is to bring safe & efficient solutions to patients with high unmet medical needs. Microbiome, Obesity, Gut modulator, Cardiometabolism, Cardiometabolic diseases, Microbiota, and Gut microbiota

298 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, …

198 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For …

633 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Sharp understanding of the hardest things At Sagacity Health, we discover new horizons in oncology by merging Agentic AI with Biotech to decode the secret world inside tumors - turning unseen ecosystems into the next frontier of precision therapeutics. Our main objective is to bridge groundbreaking science, clinical partnerships, and industrial-scale innovation to bring first-in-class therapies from lab to patient. This is not just drug development; it is a paradigm shift in how we fight cancer.

265 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I.

Health and life sciences Life Avocats is a law firm that advises and supports companies in the digital health and life sciences sector in dealing with all regulatory issues relating to the life cycle of their solutions and products: development, pre-clinical and clinical research, market access, distribution, health inspections. Life Avocats' clients are pharmaceutical laboratories, biotechs, medtechs, manufacturers and distributors of medical devices and in vitro diagnostic medical devices, publishers of digital health solutions, manufacturers of cosmetic products, food supplements or biocides, service providers serving the health product industry, academic research teams, health professionals and health establishments carrying out innovative …

58 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Partner in your clinical research. Your success: our challenge. MEDICAL INITIATIVES supports you in the design, implementation and execution of your clinical investigations. ​

64 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

In Vivo E-Health Therapeutic Education IVEHTE, the digital tool that rethinks therapeutic education for chronic pathologies. Our digital solution, the result of a collaboration between caregivers, regulatory experts and patient partners, places patient partner journeys at the heart of our support. IVEHTE initiates behavioral change by integrating medical, dietary, physical and psychological approaches. Our goal? Propose a holistic approach for lasting life changes. Partners: @Deeptechinnov, @CapDigital, @Medicen, DUMG Toulouse, @Airbus

139 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

At Nūmi, we're on a mission to redefine infant health through groundbreaking research and innovations. We’re working to recreate the magic of in vivo breast milk in vitro, offering parents a natural choice when breastfeeding isn’t an option.

80 similar entities Type: Startup Activities: healthtech deeptech Technologies: Bio sourced materials

Targeting the Source. Transforming the Outcome. We develop miRNA-based therapies that address the root causes of neurological diseases. This goes far beyond the limitations of current treatment options, which only manage individual symptoms.

157 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

FOR ANIMALS. FOR HEALTH. FOR YOU. Zoetis is a global animal health company dedicated to supporting our customers and their businesses in ever-better ways. Building on 60 years of experience, we deliver high-quality medicines, vaccines, support and education. Every day, we work to better understand and address the real-world challenges faced by the people who own and care for animals, in ways that matter most to them.

74 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

CDMO expert specialized in gene delivery It is with deep regret that we announce the liquidation of FlashTherapeutics and the end of its activities. Over the years, FlashTherapeutics has been driven by the ambition to innovate and bring transformative solutions to patients. This journey would not have been possible without the dedication of our talented team, the trust of our partners and clients, and the unwavering support from all those who believed in our mission. We want to warmly thank all employees, collaborators, and stakeholders who contributed to this adventure. Your commitment, creativity, and passion have left a lasting mark. …

56 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Seeking a cure for Amyotrophic Lateral Sclerosis (ALS). Molefy Pharma is a biotech spin off dedicated to pioneering groundbreaking treatments for neurodegenerative diseases. Our mission is clear: To develop a therapy that not only slows but reverses disease progression, bringing real hope to patients and their families. Backed by scientific excellence and a deep commitment to those affected, we are determined to make a lasting impact. Biotechnology, ALS, and Neurodegenerative Diseases

88 similar entities Type: Startup Activities: biotech deeptech

At Trilliome, we're dedicated to enhancing healthspan and quality of life through groundbreaking, microbiome-targeting precision nutraceuticals. Our innovative, plant-derived supplements are scientifically formulated to optimize gut and brain health by promoting beneficial bacteria while suppressing harmful ones. With a robust foundation in research and an unwavering commitment to sustainability, our solutions address the global health crisis resulting from poor lifestyle choices. Led by seasoned industry professionals with PhDs and MBAs and with extensive experience in life sciences and microbiome research, Trilliome aims to transform the gut health market and empower individuals worldwide to achieve optimal longevity. Join us on this …

72 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Healing Hearts Repairon is an innovative clinical-stage biotech company in Göttingen (Lower Saxony, Germany), developing stem cell-based heart muscle tissue for the treatment of advanced heart failure. The goal is to improve the cardiac function of our seriously ill heart patients so that they can lead a normal life again.

84 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

The CanVas platform is focused on developing novel cell therapies. The CanVas platform is spearheading the development of investigational allogeneic candidates for neurologic, rare and other serious diseases. Our world class team are dedicated to advancing a wave of investigational allogeneic products through excellence in translational research, clinical development and cell manufacturing. We are developing a pipeline of off-the-shelf cell therapies based on the pioneering Can-Vas platform. This could allow for the delivery of cell therapies to patients faster when they need it most and at greater scale. Our mission is to have a transformative impact on patients’ lives by …

245 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Through neuroscience and engineering, we elevate brain performance. We invented brain photobiomodulation. Through neuroscience and engineering, we elevate brain health and neural performance with our brain photobiomodulation technology. Published research with our patented technology has produced improvements in cognition, memory and mood. From neurodegeneration to brain performance, we aspire to accelerate photobiomodulation research by collaborating with bright minds globally. neurotechnology, brain photobiomodulation, biohacking, neurofeedback, brain stimulation, wellness technology, alzheimer's research, and traumatic brain injury research

57 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Think like Nature to raise the standard of human health. Gnosis by Lesaffre have a goal: to raise the standard of human health and build a healthier world where proactive health solutions help people live stronger, longer, happier lives. By diving deep into the world of microorganisms we harness the power of nature’s biological processes to create solutions that address immediate health challenges while contributing positively to human and planetary health. Together with nutraceutical and pharmaceutical brands we develop revolutionary products that help their customers thrive. Our vision is a future where health is proactive, solutions are sustainable, and every …

83 similar entities Type: Startup Activities: healthtech biotech Technologies: Decarbonization

Gecko Biomedical is a fast-paced medical device company, dedicated to the development of innovative tissue reconstruction solutions. We are leveraging our technology platforms to develop novel solutions to disrupt the field of surgery and positively impact the life of patients.

153 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

SuriCog was founded in mid-2013 by Marc Massonneau, serial entrepreneur in medical devices & services, and some other passionate people, to develop new generation of gaze-based diagnostic tools in order to improve patient pathways in neurology and psychiatry. In 2016, we acquired a company which developed a 10M€ program for best-in-class eye-movement acquisition and analysis solutions in several key neurological diseases Drawing from over a quasi-decade of eye studies, algorithm development, optoelectronics design, high-end software, and clinical trials and applications, we have advanced our technology for integration in a data-driven complete solution, as the fundamental for medical oriented eye-tracking. The …

126 similar entities Type: Startup Activities: manufacturing deeptech healthtech biotech Technologies: Synthetic Biology

Fighting chronic and fatal diseases Tirecat Health is a company developing a family of novel polymers with amazing potential in the healthcare field. We are propelled with purpose to fight chronic and fatal diseases affecting patients worldwide using our revolutionary technology to improve their quality of life. In order to make this purpose a reality, the company is preparing to move towards the clinical phase to demonstrate the astonishing results seen in preclinical trials.

300 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Revolutionary Science, Biological Wisdom. For every giant leap in technology, the human body remains our most remarkable machine: this belief has led Professor Augustinus Bader, one of the foremost scientists of his generation, to unlock the body's healing code. His breakthrough medical treatment activates and orchestrates the body's own stem cells to repair and regenerate. From skincare to clinical practice to biotech research, all our advances are grounded in a belief that the body is its own best therapist.

56 similar entities Type: Startup Activities: cosmetics Technologies: Synthetic Biology

Our mission for +25 years is to take care of people's health with an eye toward the future and innovation. We are moved by values ​​such as commitment, honesty and the desire to improve. Thanks to them and our team we have become the 3rd pharmaceutical laboratory that sells the most units in Spanish pharmacies. We are also pioneers in biosimilar drugs in Spain and Portugal and we also have a line of self-care products, sports nutrition under the Finisher brand and women's health under the Gynea brand. Our vocation to serve society means that we are always close to …

271 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the …

119 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Add Life to Years. We build Digital Therapeutics for better prevention of dementia and treatment of cog. decline (MCI) Caring for our brain should be fun and engaging. Five Lives is a brain health Digital Therapeutics (DTx) platform empowering people aged 50+ to enhance their cognitive resilience and "add life to years." It spans two critical areas: - Prevention: Five Lives mobile app for healthy “worried-well” (200,000+ users), combining clinically validated brain health assessment and monitoring with personalised gamified lifestyle coaching and science backed brain games - Therapy: Five Lives Care app, cognitive remediation for MCI patients (Mild Cognitive Impairment …

58 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Sinnotest® supports rheumatologists in optimizing the prescription of biotherapies in rheumatology SINNOVIAL is a biotechnology company that develops personalized medicine devices to improve the management of Chronic Inflammatory Rheumatism (RIC) in Rheumatology (rheumatoid arthritis, ankylosing spondylitis, in particular). Our mission: to improve the quality of life of patients by maximizing the chances of success of their treatment with biotherapy. Our objective: to provide the doctor with a device to assist in therapeutic orientation which allows him, in real time, to optimize the selection of biotherapy. “The right treatment, to the right patient, at the right time!” » Biotechnology, Rheumatology, Medtech, …

103 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Pioneering bio||intelligence for a healthier and sustainable future. Spartha Medical harnesses AI-driven bio||intelligence to engineer advanced biopolymer-based active interfaces with inherent antimicrobial, anti-inflammatory, and biocompatible properties. Our technology platform integrates biological data analysis and adaptive AI to design dynamic microstructures that neutralize pathogens, reduce infection risks, and enhance safety across medical devices, textiles, and industrial surfaces. Aligned with the One Health framework, we address interconnected human, animal, and environmental health challenges by preventing antimicrobial resistance, mitigating cross-species infections, and promoting sustainable material innovation. Committed to the UN Sustainable Development Goals (SDGs), we advance SDG 3 (Good Health), SDG 9 (Industry …

71 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: New Materials Synthetic Biology

Medincell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition …

577 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Working to build a health system that is effective, efficient, & driven by a clear vision: patient needs above all else. The Milken Institute's FasterCures believes that transformative and life-saving science should be fully realized and deliver better treatments to the people who need them. biomedical research, R&D collaboration, science policy, venture philanthropy, Partnering for Cures, science communications, medical research, and Health Citizenship

54 similar entities Type: SMB Activities: biotech deeptech

Translating genetic discoveries into safe and effective treatments. Arctic Therapeutics is a clinical-stage biopharmaceutical company on a mission to treat and even prevent some of the world’s most pressing diseases by utilizing genetic sequencing to analyze and map the genetic causes of diseases at a granular level, applying our findings to develop effective treatments. Our company was founded by Dr. Hakon Hakonarson in 2015 as a spin-off from the US-based Center for Applied Genomics (CAG), which he launched in 2006 and established it as the largest pediatric biobank and genomic database in the world. We maintain close research relationships with …

368 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transformative vascular implants. Addressing major life-threatening diseases, backed by Nobel-winning science. Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. www.xeltis.com

95 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

In 2005, we were founded on a unified belief that neuromodulation could be used in novel ways to help patients break free from treatments they aren’t happy with. Because different modalities of neuromodulation had previously proven to be effective and safe, we recognized an opportunity to be the leader in this new frontier of medicine and took it head on. Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop safe and clinically backed treatments. Bringing new treatments to market …

98 similar entities Type: SMB Activities: healthtech biotech deeptech

We’re EnovisTM – a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We strive to make each day better by partnering with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. We do this through our extraordinary talent, a laser focus on innovation, strategic acquisitions, and a common culture of continuous improvement. With more than 7,000 incredible employees worldwide and an extensive range of products, services, and integrated technologies …

232 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Confidence grows like a shared smile. Our missions: - Restore confidence and self-esteem through a smile. - Guarantee user safety through compliance with the regulatory context linked to our medical devices. - Propose innovative solutions adapted to the needs of totally edentulous people and healthcare professionals.

239 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Enabling drug delivery to the brain. TheraSonic is revolutionizing the treatment of brain diseases by enhancing non-invasive drug delivery to the brain using focused ultrasound technology. Our innovative approach aims to transform neurological care and improve patient outcomes. --- TheraSonic révolutionne le traitement des maladies cérébrales en améliorant la délivrance de médicaments dans le cerveau grâce à des ultrasons focalisés non-invasifs. Notre approche innovante vise à transformer les soins neurologiques et à améliorer les résultats pour les patients.

60 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Transforming lives with personalised, accessible, adaptive phage therapy to help clinicians cure complex infections Our mission is to transform lives with personalised, accessible, adaptive phage therapy that cures difficult bacterial infections and restores hope for patients. To ensure every bacterial infection can be effectively treated and to restore hope for patients with no remaining options.

61 similar entities Type: Startup Activities: healthtech deeptech

Captor Therapeutics is a publicly-listed (WSE:CTX) innovative drug discovery and development company focused on targeting the undruggable proteome using targeted protein degradation. Our mission is to transform lives of patients suffering from cancer, autoimmunity and neurodegenerative diseases. Our groundbreaking technology is perfectly suited to create new drug candidates with the potential to ease patients' burden and cure conditions that so far have only been poorly treatable. Captor Therapeutics S.A. implements projects co-financed by the European Union. All information about the projects is available at: https://captortherapeutics.com/grant-projects. drug development, biotechnology, and protein degradation

734 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Overcoming Challenges, Innovating Hope An innovative molecule to reshape the future of the brain Glyx Therapeutics is dedicated to transforming the lives of patients by pioneering innovative treatments for neurodegenerative disorders with urgent, unmet medical needs. Our work focuses on tackling orphan tauopathies and Alzheimer’s disease, bringing hope and solutions to those facing these challenging conditions.

174 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Swiss Rockets: Innovating breakthrough medicines and transforming healthcare globally. The Swiss Rockets mission is to deliver outstanding results for patients, inventors, and investors. Founded in 2018 in Basel, Swiss Rockets is implementing a paradigm shift in healthcare. Cancer patients will benefit from new treatment therapies developed using innovative and disruptive methods. The Swiss Rockets team combines the necessary specialist knowledge and experience to efficiently and sustainably break new ground in cancer medicine. We aim to set new paradigms in healthcare. Disruptive innovation in everything we do will allow us to deliver breakthrough treatments to patients with cancer. We conduct our …

64 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

We fight for children's lives We fight for answers. Answers that can lead to cures, treatment and medical breakthroughs. Action Medical Research is a UK-wide charity funding vital research to help sick and disabled babies and children. We fight for answers that can lead to cures, treatments and medical breakthroughs for some of the toughest fights our children face. Since we began in 1952, we have been funding medical breakthroughs and almost everyone has been touched in some way by our groundbreaking work - like the first polio vaccines in the UK, ultrasound in pregnancy and the rubella vaccine. Today, …

69 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress. BioNTech was founded in …

270 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical …

69 similar entities Tags: FrenchTech2030 Type: Startup Activities: healthtech biotech Technologies: A.I. Synthetic Biology

StemInsure®: Your Younger Cells For Life® Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients.

62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases Lipum aims for better quality of life for the millions suffering from chronic inflammatory diseases, including children. Distressed by pain, disability, and comorbidities many have to leave a normal working life in advance. We intend to increase their quality of life and decrease the considerable health care and societal costs. Inflammatory diseases, Drug development, Preclinical research, Blockbuster drugs, Chronic diseases, and Orphan drug designation

204 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Because Patients Can't Wait® As the largest life sciences association in New Jersey, BioNJ is a powerful network of over 400 Member companies representing research-based life sciences companies and stakeholders. Because Patients Can’t Wait®, we are dedicated to propelling the rich innovation ecosystem in the New Jersey region to stimulate and support innovation, improve and save lives, and lower the hurdles of healthcare advancements for society. As the industry’s voice in New Jersey, we fulfill our mission by ensuring that: Science is Supported Companies are Created Drugs are Developed Patients are Paramount Biotechnology, Pharmaceuticals, Life Sciences, New Jersey, Networking, Advocacy, …

60 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Leading Animal Cell Therapy - Improving Animal Healthcare. Vetbiobank is a biotech company specialized in veterinary regenerative medicine. For our customers and their animal companions (dogs, cats, horses), we are leveraging the unique biological potential of neonatal stem cells. Those stem cells deliver locally an appropriate set of bioactive messages to organise and promote the harmonious healing of injuries or dampen inflammatory chronic diseases. Funded in 2011, Vetbiobank has built its expertise on the experience of its founder, former expert in human cell therapy development, and cord blood derived stem cells. The mission of Vetbiobank is to provide veterinarians with …

63 similar entities Type: Startup Activities: pettech biotech deeptech Technologies: Synthetic Biology

Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology

616 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Regain control with personalized muscle regeneration MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a therapeutic platform for the regeneration of skeletal muscle tissue based on autologous cells, not only repairing damaged tissue but also increasing the regenerative potential of weakened muscles. Our initial area of focus is the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthy life.

85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Empresa española de bioingeniería que impulsa tu bienestar, para más vida y mejor vida. At Biow, we are pioneering innovative solutions that harness the power of science to enhance human well-being naturally. Our advanced technology works by reducing oxidative stress and maximizing cellular energy (ATP production), leading to a healthier, more energetic life. Backed by scientific research, our device delivers bioavailable anions that are absorbed through the skin and lungs, offering a natural way to boost your body’s ability to fight oxidative damage and improve overall vitality. Our commitment goes beyond innovation—we prioritize sustainability, transparency, and responsibility in everything we …

88 similar entities Type: Startup Activities: healthtech Technologies: Bio sourced materials

pioneering innovation in preventive medicine Hylomorph is an innovative Medtech company engineering innovative medical devices and drug-device combos that prevent implant complications and ensure patients' well-being post-surgery. At Hylomorph, we believe that every person deserves access to the best possible healthcare. That is why we are committed to developing innovative solutions that address medical needs and improve patient outcomes. By leveraging cutting-edge technologies and collaborating with healthcare professionals, we strive to make a positive impact in the lives of individuals and their families. We aim at preventing post operative complications in implantable medical devices. Our mission is to improve quality …

198 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

We develop health technology that makes life better for people. DTU Health Tech educates the engineers of the future, and develop new technology and solutions with a vision to improve people's life before, during and after they are patients. We do this in close collaboration with the health sector, industry, academia and other health partners, because we believe that the best results and ideas often occur in a close collaboration between different sectors. Health technology, Bioinformatics, Biomimetics, Biotherapeutic engineering, Digital health, Drug delivery, Immunology, Hearing research, Magnetic resonance, Medical isotopes, Dosimetry, Optical sensing, Ultrasound, Biomechanics, Engineering, Education, Research, and Innovation

104 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Built on Trust, Toward Innovation Celltrion is a fully integrated biopharmaceutical company dedicated to delivering innovative and affordable medications to improve patients’ access to advanced therapies. Pioneering monoclonal antibody (mAb) biosimilars, built on a legacy of trust, we are advancing antibody-based biologics to address unmet medical needs. Our end-to-end capabilities - from R&D to distribution - ensure efficiency, quality, and innovation at every stage, bringing life-changing therapies to patients worldwide. Partnering with purpose, we are committed to driving customer intimacy to co-creating value at every touchpoint across the care journey. #BuiltonTrustTowardInnovation For guidelines: https://bit.ly/4jv2wf2 To transform possibility into a reality …

160 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking. We are committed to seeking better outcomes which compels us to ask questions that have not been asked before or remain unresolved. We are driven by a desire to create meaningful impact across business, health and society to ease the burden on people living with chronic diseases. Intarcia is a rapidly emerging biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease. Our cross-disciplinary teams include forward-thinking scientists and entrepreneurs collaborating in a fast-paced environment redefining the future of medicine.

81 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. Our pipeline is both in Human and Veterinary medicine. Our drugs are …

370 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Advancing Human Resilience to Radiation. OUR MISSION: Protecting Lives Against Radiation Threats. USIL Therapeutics pioneers breakthrough medical solutions to safeguard people from the dangers of ionizing radiation. Our mission is to transform radiation defense with treatments and potential cures that go beyond symptomatic care, delivering true whole-body protection. Partnering with governments, defense, and energy sectors worldwide, we provide scalable, effective countermeasures that strengthen resilience and global preparedness in the face of nuclear and radiological risks. Radiation Protection and Drug Development

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming lives with groundbreaking treatments Coultreon Biopharma's mission (formerly Onco3R Therapeutics) is to develop life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs. The team is leveraging their knowledge and expertise to bring transformative innovations to patients suffering from auto-immune diseases. In this field, there is an urgent need for more convenient oral drugs that can offer greater efficacy with a better safety profile. Drug Discovery, Drug Development, Immunology, Biotech, and R&D

826 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming the lives of patients through gene therapy uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases. aav, Huntington's disease, gene therapy, ALS, epilepsy, and Fabry disease

257 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Treating Neurodegenerative Disease by Restoring Autophagy At Samsara Therapeutics, we’re on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases. Our innovative approach aims to delay the progression of several debilitating conditions, offering new possibilities for patients and their families. biotechnology, biopharmaceuticals, rare disease, neurodegeneration, longevity, drug discovery, and drug development

428 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Preserving the PromiseTM - We believe the promise of cell and gene therapies starts with the integrity of a single cell. Preserving the PromiseTM The human body can heal itself. Cell and gene therapies are designed to augment the patient’s ability to fight disease but only if the living cells behind those therapies remain viable and functional throughout the production processes. At BioLife Solutions, our mission is to protect the integrity of cells and provide trusted tools, services, and expertise that can enable our customers to advance the development and delivery of cell and gene therapies. We believe the future …

80 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Accelerating Global Health Through Bioscience Dalan's novel platform technology has introduced the world's first-ever honeybee vaccine, marking a pivotal milestone for the industry. Our mission is to safeguard the planet’s most underserved animal species, ensuring their continued well-being for global food security and the overall health of our planet.

82 similar entities Type: Startup Activities: pettech healthtech biotech Technologies: Synthetic Biology

Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences

214 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We develop, optimise and distribute innovative pharmaceutical products that offer a unique solution Who we are: Green Park Pharma UK Ltd. is a pharmaceutical company specialising in innovative drug delivery formulations. Our products address a significant market need across major global markets where the team has successfully operated. Our mission: Our mission is to develop, optimise and distribute innovative pharmaceutical products that offer a unique solution for unmet patient needs across all major global markets. Learn more about us and get in touch

282 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Measuring Cells at Quantum Scale QT Sense B.V. is a pioneering Quantum Sensing Technology company based in the Netherlands, dedicated to revolutionizing biomedical research through the power of quantum mechanics. With a decade-long collaboration at the University Medical Center Groningen (UMCG), our team has conducted groundbreaking experimentation utilizing diamond magnetometry and confocal microscopy on living organisms. This research has unveiled profound insights into the role of free radicals resulting from oxidative stress on various health conditions. Building upon our extensive research, QT Sense has developed Quantum Nouva, a state-of-the-art diagnostic and research tool. Quantum Nouva is specifically designed to address …

62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A biotech startup redefining our most basic understanding of the ageing process Based at the Babraham Research Campus in Cambridge, LinkGevity is a pioneering drug discovery company founded on ground-breaking research in longevity science. Our goal is to change the paradigm of ageing, paving the way for people to live healthier lives for longer. Contact us on info@linkgevity.com

129 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Innovative therapeutic procedures for Intensive Care Medicine for the treatment of severe infections / sepsis ARTCLINE GmbH develops innovative therapy methods for intensive care medicine based on immune cells. Our current main project is the development of the so-called ARTICE technology for the treatment of bacterial sepsis. ARTCLINE's vision is the development of innovative immune cell-based therapy approaches and to make the technology available to physicians and hospitals worldwide. The safety and effectiveness of the therapy is our top priority. Our extensive cell biological, clinical and industrial experience in the fields of immunology, sepsis diagnostics and therapy help us to …

94 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Committed to saving lives. Hemarina is an innovative biotechnology company specializing in health product development based in Morlaix (29600, FR). Our search for new solutions based on the properties of the haemoglobin of the arenicola marina worm is permanent to improve the quality of life of patients and their families. Our commitment: to save lives by putting the patient at the heart of all our actions. BioTech, Ocean, Biomimicry, Biology, Biodiversity, and Transplantation

77 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Connecting Brains WE ́RE NOT CURRENTLY HIRING MISSION & VALUES To serve our patients we design affordable, safe and effective therapeutics to safeguard and empower the brain throughout all stages of life. We value partnership and Integrity, we are ethical and responsible and show respect and compassion for our patients. R&D STRATEGY The successful companies of tomorrow are those that go beyond delivering products to delivering real solutions and services. R&D is the cornerstone of our company and we promote ingenuity through an effective intellectual property policy. The advancements in science mean that more targeted, more (cost-)effective treatments are within …

183 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Biotech’s daily dose of laughter Welcome to BioLaughs.com – the only petri dish where science, sarcasm, and storytelling happily co-culture. We know biopharma and life sciences can sometimes feel like a never-ending clinical trial of patience, so we’re here to provide your daily dose of humour — side effects may include uncontrollable chuckles, lab-bench banter, and spontaneous sharing with colleagues. From PCR punchlines to CRISPR quips, from drug discovery drama to boardroom bloopers, we celebrate the lighter side of science. After all, if you can’t laugh at your own genome, whose can you laugh at?

58 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing transformative solutions for patients with infectious diseases and other difficult to treat conditions Positive Outcomes. Positive Patient Stories®. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that …

71 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

We are a biopharmaceutical company dedicated to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

284 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Transforming Research, Advancing Health Together At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation …

132 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology

HIRING! Biotech makes the world a better place to live, so we’re making labs that are a better place to work. With so much potential for biotech to make the world a better place to live, we knew we needed to make the lab a better place to work. We’re a team of scientists and designers who have meticulously studied the in-lab experience, getting a detailed understanding of workflows and identifying common pain points that routinely cost scientists time and money. Our BioHotel labs are designed with biotech startups in mind: - Short term, flexible leases - Central London locations …

59 similar entities Type: Startup Activities: biotech deeptech

Bridging research and translation for a healthy future. ImmuneBridge is building a world where high quality cell therapies can be rapidly designed and easily manufactured at commercial scale and ultralow cost. Cell Therapy, Immunotherapy, CAR-NK, Natural Killer Cells, and Oncology

182 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ayudamos a vivir más y mejor We are an Argentine pharmaceutical company formed by a group of multidisciplinary professionals who are committed to excellence and ongoing improvement. We develop and manufacture quality pharmaceutical products with a human added value. We share a vision of a world where health is not a privilege. Therefore, we would like to make our contribution to improve, protect and care for human life.

56 similar entities Type: SMB Activities: healthtech manufacturing